Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Psychology and Aging
|
June 1, 1994
Adult age differences in impression change processes
T M Hess, S M Pullen
Psychology and Aging
|
March 1, 1996
Acquisition of prototype-based information about social groups in adulthood
T M Hess, S M Pullen, K A McGee
Journal of Medicinal Chemistry
|
January 1, 1990
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines
B D Palmer, W R Wilson, S M Pullen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction
W A Denny, W R Wilson, M Tercel, et al.
British Journal of Cancer
|
March 5, 2004
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT
N A Helsby, D M Ferry, A V Patterson, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide
H H Lee, W R Wilson, D M Ferry, et al.
Biochemical Pharmacology
|
September 7, 2000
Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism
B G Siim, K O Hicks, S M Pullen, et al.
Journal of Medicinal Chemistry
|
April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs
B G Siim, G J Atwell, R F Anderson, et al.
Anti-Cancer Drug Design
|
October 1, 1996
Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase
G J Atwell, M Boyd, B D Palmer, et al.
The British Journal of Cancer. Supplement
|
July 1, 1996
Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N
W R Wilson, W A Denny, S M Pullen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Psychology and Aging
|
June 1, 1994
Adult age differences in impression change processes
T M Hess, S M Pullen
Psychology and Aging
|
March 1, 1996
Acquisition of prototype-based information about social groups in adulthood
T M Hess, S M Pullen, K A McGee
Journal of Medicinal Chemistry
|
January 1, 1990
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines
B D Palmer, W R Wilson, S M Pullen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction
W A Denny, W R Wilson, M Tercel, et al.
British Journal of Cancer
|
March 5, 2004
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT
N A Helsby, D M Ferry, A V Patterson, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide
H H Lee, W R Wilson, D M Ferry, et al.
Biochemical Pharmacology
|
September 7, 2000
Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism
B G Siim, K O Hicks, S M Pullen, et al.
Journal of Medicinal Chemistry
|
April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs
B G Siim, G J Atwell, R F Anderson, et al.
Anti-Cancer Drug Design
|
October 1, 1996
Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase
G J Atwell, M Boyd, B D Palmer, et al.
The British Journal of Cancer. Supplement
|
July 1, 1996
Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N
W R Wilson, W A Denny, S M Pullen, et al.
Page
of 1